| Announce Date | 11/19/2025 |
| EPS Normalized Actual | $0.02 (Beat by $0.12) |
| EPS GAAP Actual | $0.02 (Beat by $0.12) |
| Revenue Actual | $2.46508B |
| Revenue Surprise | Beat by $2465.08M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.33406 |
| EPS GAAP Estimate | $-0.33406 |
| Revenue Estimate | $1.619939731B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 2.76618 | 5.22 | 2.46975 | 2.96305 | 3 |
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0165 | 0.60935 | 2.46508B | 23.51% | 2105.3M |
| FQ2 2025 (Jun 2025) | -1.8 | -1.31925 | 2.34923B | 19.47% | 2066.54M |
| FQ1 2025 (Mar 2025) | -18.9 | -18.4918 | 1.96998B | 9.86% | 1725.84M |
| FQ4 2024 (Dec 2024) | -0.8 | -0.00178 | 2.23214B | 22.83% | 1919.2M |
| FQ3 2024 (Sep 2024) | 0 | -1.54141 | 1.88557B | 13.81% | -2244.09M |
| FQ2 2024 (Jun 2024) | -1.45 | -1.45 | 1.89178B | 2.98% | 1891.78M |
| FQ4 2018 (Dec 2018) | -5.51 | -5.51 | 0.724341B | 100% | 724.34M |
| FQ1 2024 (Mar 2024) | -1.49 | -1.49 | 1.77568B | -5% | 1775.68M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.33406
Consensus Revenue Estimates
1.619939731B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.35995 | -- | -0.36919 | -0.353 | 1 |
| FQ3 2027 (Sep 2027) | -0.3081 | -- | -0.31906 | -0.27767 | 1 |
| FQ2 2027 (Jun 2027) | -0.28768 | -- | -0.29792 | -0.25927 | 1 |
| FQ1 2027 (Mar 2027) | -0.30385 | -- | -0.31165 | -0.29798 | 1 |
| FQ4 2026 (Dec 2026) | -0.53022 | -- | -0.53264 | -0.52543 | 0 |
| FQ3 2026 (Sep 2026) | -0.48118 | 96.57 | -0.48338 | -0.47683 | 0 |
| FQ2 2026 (Jun 2026) | -0.3831 | -369.85 | -0.38485 | -0.37964 | 0 |
| FQ1 2026 (Mar 2026) | -0.33406 | -5557.67 | -0.33559 | -0.33104 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.97B | -- | 3.91B | 4.05B | 1 |
| FQ3 2027 (Sep 2027) | 3.48B | -- | 3.22B | 3.58B | 2 |
| FQ2 2027 (Jun 2027) | 2.73B | -- | 2.53B | 2.81B | 2 |
| FQ1 2027 (Mar 2027) | 2.43B | -- | 2.4B | 2.48B | 1 |
| FQ4 2026 (Dec 2026) | 2.64B | -- | 2.62B | 2.65B | 1 |
| FQ3 2026 (Sep 2026) | 2.39B | -3.26 | 2.37B | 2.4B | 1 |
| FQ2 2026 (Jun 2026) | 1.88B | -25.24 | 1.86B | 1.88B | 1 |
| FQ1 2026 (Mar 2026) | 1.62B | -21.61 | 1.61B | 1.63B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.62585 | -0.0165 | 0.60935 | -3693.03% |
| FQ2 2025 (Jun 2025) | -0.48075 | -1.8 | -1.31925 | 73.29% |
| FQ1 2025 (Mar 2025) | -0.4082 | -18.9 | -18.4918 | 97.84% |
| FQ4 2024 (Dec 2024) | -0.79822 | -0.8 | -0.00178 | 0.22% |
| FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
| FQ2 2024 (Jun 2024) | -1.45 | -1.45 | 100% | |
| FQ4 2018 (Dec 2018) | -5.51 | -5.51 | 100% | |
| FQ1 2024 (Mar 2024) | -1.49 | -1.49 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.36B | $2.47B | $2105.3M | 85.4% |
| FQ2 2025 (Jun 2025) | $0.28B | $2.35B | $2066.54M | 87.97% |
| FQ1 2025 (Mar 2025) | $0.24B | $1.97B | $1725.84M | 87.61% |
| FQ4 2024 (Dec 2024) | $0.31B | $2.23B | $1919.2M | 85.98% |
| FQ3 2024 (Sep 2024) | $4.13B | $1.89B | $-2244.09M | -119.01% |
| FQ2 2024 (Jun 2024) | $0B | $1.89B | $1891.78M | 100% |
| FQ4 2018 (Dec 2018) | $0B | $0.72B | $724.34M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.78B | $1775.68M | 100% |